v3.26.1
Share Capital - Schedule of Issued and Outstanding Common Shares (Details) - Issued Capital [Member] - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Schedule of Issued and Outstanding Common Shares [Line Items]      
Number of Common shares, Opening balance 90,883 3,583
Amount of Common shares, Opening balance (in Dollars) $ 61,752,305 $ 46,125,397 $ 5,934,141
Number of Common shares, Shares issued on conversion of convertible note   6,105  
Amount of Common shares, Shares issued on conversion of convertible note (in Dollars)   $ 4,617,286  
Number of Common shares, Shares issued on conversion of convertible note warrants   3,660  
Amount of Common shares, Shares issued on conversion of convertible note warrants (in Dollars)   $ 639,954  
Number of Common shares, Shares issued for ELOC 1,051,973 35,024  
Amount of Common shares, Shares issued for ELOC (in Dollars) $ 14,545,896 $ 6,692,495  
Number of Common shares, Commitment shares ELOC   543  
Amount of Common shares, Commitment shares ELOC (in Dollars)   $ 187,500  
Number of Common shares, Share issuance costs for ELOC  
Amount of Common shares, Share issuance costs for ELOC (in Dollars) $ (581,836) $ (469,600)  
Number of Common shares, Warrant exchange   177  
Amount of Common shares, Warrant exchange (in Dollars)   $ 192,060  
Number of Common shares, Shares issued on conversion of PGI promissory notes   7,562  
Amount of Common shares, Shares issued on conversion of PGI promissory notes (in Dollars)   $ 988,569  
Number of Common shares, Shares issued on conversion of NCAC promissory notes   8,364  
Amount of Common shares, Shares issued on conversion of NCAC promissory notes (in Dollars)   $ 1,096,358  
Number of Common shares, Shares issued for PsyLabs share exchange   5,695  
Amount of Common shares, Shares issued for PsyLabs share exchange (in Dollars)   $ 722,033  
Number of Common shares, Shares issued for PIPE financing   7,629  
Amount of Common shares, Shares issued for PIPE financing (in Dollars)   $ 313,628  
Number of Common shares, Share issuance costs for PIPE financing    
Amount of Common shares, Share issuance costs for PIPE financing (in Dollars)   $ (40,449)  
Number of Common shares, Shares issued for PIPE pre-funded warrants exercised   12,447  
Amount of Common shares, Shares issued for PIPE pre-funded warrants exercised (in Dollars)   $ 511,690  
Number of Common shares, Shares issuance costs for PIPE pre-funded warrants exercised    
Amount of Common shares, Shares issuance costs for PIPE pre-funded warrants exercised (in Dollars)   $ (65,995)  
Number of Common shares, Share issuance to PGI     1,338
Amount of Common shares, Share issuance to PGI (in Dollars)    
Number of Common shares, Share issuance to NCAC shareholders     2,086
Amount of Common shares, Share issuance to NCAC shareholders (in Dollars)     $ 37,336,416
Number of Common shares, Shares issued for debt settlement     40
Amount of Common shares, Shares issued for debt settlement (in Dollars)     $ 718,500
Number of Common shares, Shares issued to third party advisors 2,439 94 119
Amount of Common shares, Shares issued to third party advisors (in Dollars) $ 60,000 $ 241,379 $ 2,136,340
Number of Common shares, Share issuance for Associate 1,146,159    
Amount of Common shares, Share issuance for Associate (in Dollars) $ 2,934,167    
Number of Common shares, Exercise of RSUs 1,823    
Amount of Common shares, Exercise of RSUs (in Dollars) $ 37,451    
Number of Common shares, Ending Balance 2,293,277 90,883 3,583
Amount of Common shares, Ending Balance (in Dollars) $ 78,747,983 $ 61,752,305 $ 46,125,397